| Literature DB >> 32914769 |
Sharon R Silver1, Jia Li1, Winifred L Boal1, Taylor L Shockey1, Matthew R Groenewold1.
Abstract
Certain underlying medical conditions are associated with higher risks for severe morbidity and mortality from coronavirus disease 2019 (COVID-19) (1). Prevalence of these underlying conditions among workers differs by industry and occupation. Many essential workers, who hold jobs critical to the continued function of infrastructure operations (2), have high potential for exposure to SARS-CoV-2, the virus that causes COVID-19, because their jobs require close contact with patients, the general public, or coworkers. To assess the baseline prevalence of underlying conditions among workers in six essential occupations and seven essential industries, CDC analyzed data from the 2017 and 2018 Behavioral Risk Factor Surveillance System (BRFSS) surveys, the most recent data available.* This report presents unadjusted prevalences and adjusted prevalence ratios (aPRs) for selected underlying conditions. Among workers in the home health aide occupation and the nursing home/rehabilitation industry, aPRs were significantly elevated for the largest number of conditions. Extra efforts to minimize exposure risk and prevent and treat underlying conditions are warranted to protect workers whose jobs increase their risk for exposure to SARS-CoV-2.Entities:
Mesh:
Year: 2020 PMID: 32914769 PMCID: PMC7499835 DOI: 10.15585/mmwr.mm6936a3
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
Demographic characteristics of selected essential workers, by industries (I) and occupations (O) — Behavioral Risk Factor Surveillance System, 31 U.S. states,* 2017–2018
| Worker grouping† | Total respondents | No. (%)§ | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age (yrs) | Sex | Race/Ethnicity¶ | ||||||||||
| 18–49 | 50–59 | 60–69 | ≥70 | Male | Female | White | Black | Asian | Other | Hispanic | ||
| All workers** | 213,518 | 110,540 (66.0) | 54,423 (20.8) | 37,596 (10.6) | 10,959 (2.7) | 109,590 (54.9) | 103,654 (45.1) | 157,236 (59.4) | 18,088 (12.1) | 7,406 (6.5) | 10,934 (3.0) | 19,854 (19.0) |
| Occupation | ||||||||||||
| Health practitioners O = 3000–3260 | 12,208 | 5,943 (60.4) | 3,245 (23.7) | 2,519 (13.6) | 501 (2.3) | 2,703 (22.8) | 9,496 (77.2) | 9,884 (66.7) | 910 (11.5) | 506 (11.4) | 410 (1.9) | 498 (8.5) |
| Health technicians and technologists O = 3300–3535 | 3,164 | 1,760 (67.5) | 794 (20.5) | 534 (10.1) | 76 (1.9) | 730 (29.6) | 2,428 (70.4) | 2,429 (68.8) | 297 (12.2) | 104 (9.4) | 151 (2.7) | 183 (6.9) |
| Health care support (except home health) O = 3600–3655, excluding I = 8170 | 3,368 | 2,144 (76.5) | 697 (14.5) | 452 (8.0) | 75 (1.0) | 368 (11.0) | 2,997 (89.0) | 2,073 (50.7) | 626 (24.2) | 123 (4.9) | 193 (3.5) | 353 (16.7) |
| Home health patient and personal care aides O = 3600 or 4610, restricted to I = 8170 | 1,179 | 531 (59.4) | 328 (23.2) | 236 (13.4) | 84 (4.0) | 139 (10.2) | 1,040 (89.8) | 644 (39.0) | 253 (30.6) | 35 (5.3) | 92 (4.9) | 155 (20.2) |
| Protective services O = 3700–3720, 3740–3750, 3800–3860 | 2,422 | 1,618 (73.5) | 584 (21.1) | 194 (4.5) | 26 (0.9) | 1,950 (85.2) | 471 (14.8) | 1,780 (66.4) | 267 (15.3) | 38 (1.8) | 171 (3.9) | 166 (12.6) |
| Teachers O = 2300–2330 | 8,965 | 4,741 (66.6) | 2,468 (22.5) | 1,478 (9.5) | 278 (1.5) | 1,934 (23.4) | 7,020 (76.6) | 7,215 (71.6) | 708 (12.7) | 191 (3.7) | 392 (2.5) | 459 (9.5) |
| Industry | ||||||||||||
| Ambulatory health care I = 7970–8090 | 9,679 | 4,853 (63.3) | 2,444 (21.2) | 1,900 (13.0) | 482 (2.6) | 2,580 (28.5) | 7,091 (71.5) | 7,424 (63.3) | 817 (12.8) | 413 (10.6) | 460 (2.4) | 565 (11.0) |
| Hospitals I = 8190 | 12,155 | 6347 (64.1) | 3,293 (22.3) | 2,175 (11.8) | 340 (1.8) | 3,000 (27.5) | 9,138 (72.5) | 8,994 (61.0) | 1,339 (15.2) | 509 (9.5) | 527 (2.6) | 786 (11.7) |
| Nursing homes and rehabilitation I = 8270, 8290 | 3,833 | 1903 (61.9) | 973 (23.9) | 762 (11.6) | 195 (2.5) | 566 (18.4) | 3,266 (81.6) | 2,621 (54.9) | 717 (27.6) | 97 (4.8) | 162 (2.4) | 236 (10.4) |
| Essential retail I = 4970–4990, 5070, 5090 | 4,399 | 2,432 (72.2) | 998 (16.0) | 745 (9.5) | 224 (2.4) | 2,021 (54.0) | 2,372 (46.0) | 3,232 (60.3) | 304 (8.6) | 194 (7.3) | 268 (4.0) | 401 (19.8) |
| Food manufacturing I = 1070–1370 | 1,682 | 954 (71.6) | 443 (17.5) | 238 (8.0) | 47 (3.0) | 1,037 (63.7) | 642 (36.3) | 987 (44.4) | 171 (11.4) | 35 (5.1) | 73 (3.2) | 416 (35.9) |
| Transit, postal, messengers, and couriers I = 6180, 6190, 6370, 6380 | 1,932 | 836 (61.6) | 599 (23.2) | 388 (13.0) | 109 (2.2) | 1,205 (67.5) | 723 (32.5) | 1,225 (47.0) | 339 (25.6) | 79 (6.7) | 122 (4.6) | 167 (16.2) |
| Trucking I = 6170 | 2,418 | 1,134 (59.4) | 718 (23.6) | 447 (14.2) | 119 (2.8) | 2,109 (89.2) | 307 (10.8) | 1,729 (55.3) | 345 (22.5) | 41 (3.3) | 123 (3.7) | 180 (15.1) |
* California, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Indiana, Kansas, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Washington, and Wisconsin.
† By U.S. Census codes (https://www.census.gov/programs-surveys/cps/technical-documentation/methodology/industry-and-occupation-classification.html).
§ Weighted percentage.
¶ White, Black, and Asian are non-Hispanic. Other are respondents identifying as non-Hispanic and not identifying specifically as Asian, Black, or White. Respondents identifying with multiple races are asked to select the grouping that best represents their race.
** All currently employed non-active duty military respondents to the Industry and Occupation module of the 2017 or 2018 Behavioral Risk Factor Surveillance System.
Prevalence* and adjusted prevalence ratio (aPR) of underlying health conditions among essential workers, by occupation — Behavioral Risk Factor Surveillance System, 31 U.S. states, 2017–2018
| Underlying condition | All workers** | Health practitioners | Health technicians and technologists | Health care support (except home health) | Home health and personal care aides | Protective services | Teachers, pre-K–grade 12 |
|---|---|---|---|---|---|---|---|
| Asthma, current | |||||||
| % (95% CI) | 7.6 (7.4–7.9) | 10.0 (8.7–11.5) | 9.3 (7.2–11.7) | 10.3 (8.5–12.4) | 13.2 (9.6–17.6) | 6.9 (5.0–9.2) | 11.4 (9.8–13.2) |
| aPR (95% CI) | — | 1.08 (0.94–1.25) | 0.99 (0.78–1.27) | 0.98 (0.80–1.19) | 1.31 (0.96–1.78) | 1.04 (0.78–1.39) | 1.19 (1.02–1.39) |
| Asthma, ever | |||||||
| % (95% CI) | 12.8 (12.4–13.1) | 14.4 (12.7–16.1) | 14.6 (11.6–18.2) | 14.3 (12.2– 16.7) | 17.1 (12.9–22.0) | 13.6 (11.0–16.5) | 16.6 (14.6–18.8) |
| aPR (95% CI) | — | 1.04 (0.92–1.18) | 1.02 (0.81–1.28) | 0.90 (0.76–1.06) | 1.16 (0.88–1.78) | 1.11 (0.92–1.35) | 1.17 (1.03–1.33) |
| Cancer†† | |||||||
| % (95% CI) | 3.7 (3.5–3.8) | 4.0 (3.5–4.7) | 3.5 (2.7–4.6)) | 3.0 (1.9–4.4) | 5.0 (3.2–7.4) | 2.6 (1.6–3.9) | 4.3 (3.4–5.3) |
| aPR (95% CI) | — | 0.84 (0.72–0.98) | 0.85 (0.65–1.12 | 0.83 (0.57–1.22) | 1.02 (0.68–1.54) | 0.96 (0.64–1.44) | 0.96 (0.78–1.19) |
| Coronary heart disease§§ | |||||||
| % (95% CI) | 3.0 (2.8–3.2) | 2.0 (1.5–2.6) | 1.4 (1.0–2.0) | 2.2 (1.5–3.2) | 4.4 (2.0–8.3)¶¶ | 2.7 (1.5–4.5) | 1.6 (1.1–2.3) |
| aPR (95% CI) | — | 0.75 (0.57–0.99) | 0.64 (0.45–0.90) | 1.32 (0.92–1.89) | 1.80 (0.93–3.45) | 0.95 (0.57–1.57) | 0.70 (0.48–1.01) |
| Chronic kidney disease | |||||||
| % (95% CI) | 1.6 (1.5–1.7) | 1.3 (1.0–1.7) | 1.6 (0.8–2.9)¶¶ | 1.0 (0.5–1.6) | 4.6 (2.0–9.0)¶¶ | 1.6 (0.8–3.0)¶¶ | 1.4 (1.0–1.9) |
| aPR (95% CI) | — | 0.79 (0.59–1.05) | 1.07 (0.58–2.00) | 0.65 (0.37–1.12) | 2.53 (1.24–5.14) | 1.22 (0.66–2.26) | 0.90 (0.64–1.27) |
| COPD | |||||||
| % (95% CI) | 3.1 (2.9–3.2) | 1.7 (1.4–2.1) | 3.0 (2.0–4.3) | 4.0 (2.9–5.4) | 6.2 (4.0–9.0) | 2.5 (1.1–4.7)¶¶ | 2.7 (1.8–3.8) |
| aPR (95% CI) | — | 0.46 (0.37–0.57) | 0.91 (0.63–1.30) | 1.25 (0.92–1.70) | 1.68 (1.14–2.48) | 0.89 (0.46–1.71) | 0.76 (0.53–1.08) |
| Diabetes | |||||||
| % (95% CI) | 6.5 (6.3–6.8) | 5.6 (4.7–6.5) | 5.9 (4.5–7.5) | 6.6 (5.2–8.1) | 12.2 (8.2–17.4) | 7.1 (5.0–9.7) | 5.4 (3.9–7.3) |
| aPR (95% CI) | — | 0.85 (0.72–1.00) | 1.02 (0.80–1.31) | 1.36 (1.10–1.67) | 1.70 (1.21–2.39) | 1.13 (0.83–1.53) | 0.93 (0.69–1.25) |
| Hypertension*** | |||||||
| % (95% CI) | 23.7 (23.1–24.4) | 20.3 (18.1–22.6) | 23.2 (18.8–28.2) | 21.2 (17.1–25.7) | 29.3 (22.4–37.1) | 25.6 (20.4–31.3) | 17.8 (15.4–20.4) |
| aPR (95% CI) | — | 0.86 (0.78–0.96) | 1.11 (0.94–1.31) | 1.10 (0.94–1.30) | 1.15 (0.89–1.48) | 1.04 (0.86–1.26) | 0.81 (0.72–0.92) |
| Obesity (BMI≥30 kg/m2)††† | |||||||
| % (95% CI) | 29.9 (29.4–30.4) | 26.1 (23.7–28.5) | 37.4 (32.7–42.3) | 40.0 (36.6–43.5) | 44.8 (36.9–53.0) | 39.6 (35.7–43.6) | 27.3 (25.1–29.7) |
| aPR (95% CI) | — | 0.86 (0.78–0.93) | 1.27 (1.12–1.45) | 1.29 (1.19–1.41) | 1.38 (1.12–1.69) | 1.24 (1.12–1.37) | 0.86 (0.79–0.94) |
| Severe obesity (BMI≥40 kg/m2)††† | |||||||
| % (95% CI) | 4.3 (4.1–4.5) | 3.3 (2.7–4.1) | 4.1 (3.0–5.6) | 9.1 (7.2–11.2) | 9.1 (6.0–13.0) | 5.5 (3.6–8.0) | 4.9 (3.8–6.3) |
| aPR (95% CI) | — | 0.67 (0.54–0.82) | 0.86 (0.64–1.16) | 1.62 (1.29–2.03) | 1.59 (1.09–2.31) | 1.26 (0.86–1.86) | 0.95 (0.73–1.23) |
| Stroke | |||||||
| % (95% CI) | 1.2 (1.1–1.3) | 0.8 (0.5–1.1) | 1.7 (0.5–4.2)¶¶ | 0.9 (0.5–1.5) | 2.0 (0.8–3.9)¶¶ | 0.3 (0.1–0.7)¶¶ | 1.3 (0.6–2.4)¶¶ |
| aPR (95% CI) | — | 0.67 (0.47–0.95) | 1.68 (0.66–4.29) | 0.99 (0.60–1.65) | 1.50 (0.74–3.09) | 0.32 (0.16–0.66) | 1.23 (0.67–2.26) |
Abbreviations: BMI = body mass index; CI = confidence interval; COPD = chronic obstructive pulmonary disease.
* Unadjusted, weighted estimates.
† Adjusted for age group (18–29, 30–39, 40–49, 50–59, 60–69, ≥70 years), sex, race/ethnicity (non-Hispanic White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic other race, Hispanic). aPR reference group is all other occupations (essential and non-essential) combined.
§ By U.S. Census codes (https://www.census.gov/programs-surveys/cps/technical-documentation/methodology/industry-and-occupation-classification.html).
¶ California, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Indiana, Kansas, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Washington, and Wisconsin.
** All currently employed non-active duty military respondents to the Industry and Occupation module of the 2017 or 2018 Behavioral Risk Factor Surveillance System.
†† Except nonmelanoma skin cancer.
§§ Includes heart attack/myocardial infarction, coronary heart disease, or angina.
¶¶ Relative standard error >30% but ≤50%.
*** 2017 BRFSS data only, available for 22 states: California, Connecticut, Florida, Georgia, Hawaii, Illinois, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Tennessee, Washington, and Wisconsin.
††† Body mass index (and thus obesity) was missing for 9% of cohort; all other behaviors and conditions missing for <1% of cohort.
Prevalence* and adjusted prevalence ratio (aPR) of underlying health conditions among essential workers by industry — Behavioral Risk Factor Surveillance System, 31 U.S. states, 2017–2018
| Underlying condition | All workers** | Ambulatory health care | Hospitals | Nursing homes and rehabilitation | Essential retail | Food manufacturing | Transit | Trucking |
|---|---|---|---|---|---|---|---|---|
| Asthma, current | ||||||||
| % (95% CI) | 7.6 (7.4–7.9) | 9.7 (8.4–11.1) | 9.7 (8.4–11.0) | 10.1 (8.3–12.0) | 9.8 (7.7–12.3) | 4.6 (2.7–7.4) | 11.1 (7.2–16.0) | 4.3 (3.0–5.9) |
| aPR (95% CI) | — | 1.07 (0.93–1.24) | 1.06 (0.92–1.21) | 1.00 (0.83–1.20) | 1.22 (0.97–1.53) | 0.65 (0.41–1.04) | 1.52 (1.05–2.20) | 0.68 (0.50–0.94) |
| Asthma, ever | ||||||||
| % (95% CI) | 12.8 (12.4–13.1) | 15.1 (13.4–17.0) | 14.6 (12.9–16.5) | 15.0 (12.7–17.6) | 16.1 (13.5–19.0) | 9.1 (6.4–12.3) | 13.9 (10.0–18.7) | 9.5 (7.3–12.1) |
| aPR (95% CI) | — | 1.11 (0.98–1.25) | 1.05 (0.93–1.19) | 1.01 (0.86–1.20) | 1.17 (0.99–1.38) | 0.73 (0.54–0.98) | 1.13 (0.84–1.51) | 0.82 (0.65–1.05) |
| Cancer†† | ||||||||
| % (95% CI) | 3.7 (3.5–3.8) | 4.7 (4.0–5.5) | 3.7 (3.0–4.4) | 4.6 (3.2–6.3) | 3.3 (2.4–4.4) | 2.7 (1.7–4.1) | 4.0 (2.1–6.8) | 2.8 (2.0–3.8) |
| aPR (95% CI) | — | 1.05 (0.89–1.25) | 0.84 (0.70–1.02) | 0.99 (0.73–1.35) | 1.02 (0.77–1.36) | 0.86 (0.58–1.28) | 1.10 (0.66–1.84) | 0.82 (0.60–1.11) |
| Coronary heart disease§§ | ||||||||
| % (95% CI) | 3.0 (2.8–3.2) | 2.7 (1.9–3.7) | 2.0 (1.5–2.6) | 4.4 (2.8–6.5) | 3.0 (2.0–4.4) | 4.4 (2.5–7.1) | 5.0 (2.5–8.8) | 4.2 (3.0–5.8) |
| aPR (95% CI) | — | 1.02 (0.74–1.40) | 0.80 (0.62–1.04) | 1.90 (1.28–2.82) | 1.21 (0.83–1.77) | 1.45 (0.93–2.27) | 1.49 (0.84–2.66) | 1.05 (0.75–1.49) |
| Chronic kidney disease | ||||||||
| % (95% CI) | 1.6 (1.5–1.7) | 1.4 (1.1–1.8) | 1.3 (0.9–1.8) | 1.4 (0.9–2.1) | 2.1 (1.1–3.5) | 1.1 (0.4–2.5)¶¶ | 1.8 (1.1–2.7) | 1.6 (0.9–2.6) |
| aPR (95% CI) | — | 0.87 (0.66–1.15) | 0.78 (0.55–1.10) | 0.83 (0.54–1.29) | 1.40 (0.81–2.42) | 0.72 (0.31–1.65) | 1.08 (0.71–1.65) | 0.99 (0.60–1.64) |
| COPD | ||||||||
| % (95% CI) | 3.1 (2.9–3.2) | 2.5 (1.8–3.3) | 2.8 (2.2–3.4) | 5.1 (3.8–6.6) | 3.7 (2.8–4.9) | 2.4 (1.2–4.2) | 4.0 (2.6–5.7) | 5.3 (3.1–8.3) |
| aPR (95% CI) | — | 0.71 (0.53–0.96) | 0.80 (0.64–1.01) | 1.43 (1.09–1.88) | 1.28 (0.98–1.67) | 0.84 (0.48–1.47) | 1.27 (0.87–1.85) | 1.72 (1.09–2.71) |
| Diabetes | ||||||||
| % (95% CI) | 6.5 (6.3–6.8) | 6.3 (5.3–7.4) | 6.4 (5.5–7.3) | 8.3 (6.6–10.2) | 6.5 (5.1–8.2) | 7.6 (5.0–11.0) | 11.4 (8.3–15.0) | 11.1 (8.0–14.9) |
| aPR (95% CI) | — | 0.97 (0.82–1.14) | 1.01 (0.87–1.17) | 1.29 (1.05–1.59) | 1.19 (0.96–1.47) | 1.14 (0.82–1.60) | 1.40 (1.06–1.84) | 1.32 (0.97–1.79) |
| Hypertension*** | ||||||||
| % (95% CI) | 23.7 (23.1–24.4) | 23.3 (20.7–26.1) | 20.2 (18.0–22.5) | 27.7 (23.2–32.5) | 22.7 (18.8–26.9) | 26.6 (18.9–35.4) | 23.2 (18.0–29.1) | 29.6 (24.4–35.1) |
| aPR (95% CI) | — | 1.01 (0.90–1.13) | 0.90 (0.81–1.00) | 1.24 (1.08–1.43) | 1.09 (0.93–1.28) | 1.12 (0.89–1.42) | 0.85 (0.68–1.05) | 1.01 (0.85–1.20) |
| Obesity (BMI≥30 kg/m2)††† | ||||||||
| % (95% CI) | 29.9 (29.4–30.4) | 28.5 (26.4–30.7) | 30.4 (28.4–32.6) | 37.2 (33.9–40.7) | 30.4 (27.3–33.5) | 28.0 (22.3–34.2) | 29.8 (25.5–34.5) | 48.2 (43.4–53.0) |
| aPR (95% CI) | — | 0.95 (0.88–1.02) | 1.00 (0.93–1.08) | 1.17 (1.07–1.28) | 1.06 (0.96–1.16) | 0.89 (0.72–1.10) | 0.91 (0.78–1.07) | 1.50 (1.36–1.66) |
| Severe obesity (BMI≥40 kg/m2)††† | ||||||||
| % (95% CI) | 4.3 (4.1–4.5) | 4.0 (3.3–4.8) | 5.3 (4.4–6.3) | 7.9 (6.3–9.7) | 5.6 (4.2–7.2) | 2.6 (1.8–3.8) | 4.6 (3.0–6.7) | 7.7 (5.4–10.5) |
| aPR (95% CI) | — | 0.84 (0.69–1.03) | 1.10 (0.91–1.33) | 1.47 (1.19–1.83) | 1.36 (1.04–1.76) | 0.60 (0.41–0.87) | 1.02 (0.70–1.49) | 1.93 (1.40–2.65) |
| Stroke | ||||||||
| % (95% CI) | 1.2 (1.1–1.3) | 1.1 (0.6–1.8) | 1.0 (0.7–1.4) | 1.3 (0.9–1.9) | 1.0 (0.7–1.4) | 0.6 (0.3–1.0) | 1.3 (0.6–2.3)¶¶ | 0.9 (0.4–1.8)¶¶ |
| aPR (95% CI) | — | 0.94 (0.55–1.61) | 0.92 (0.66–1.28) | 1.13 (0.75–1.69) | 1.09 (0.74–1.59) | 0.52 (0.30–0.91) | 1.02 (0.55–1.90) | 0.70 (0.36–1.38) |
Abbreviations: BMI = body mass index; CI = confidence interval; COPD = chronic obstructive pulmonary disease.
* Unadjusted, weighted estimates.
† Adjusted for age group (18–29, 30–39, 40–49, 50–59, 60–69, ≥70 years), sex, race/ethnicity (non-Hispanic White, non-Hispanic Black, non-Hispanic Asian, non-Hispanic other race, Hispanic). aPR reference group is all other industries (essential and non-essential) combined.
§ https://www.census.gov/programs-surveys/cps/technical-documentation/methodology/industry-and-occupation-classification.html.
¶ California, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Indiana, Kansas, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Washington, and Wisconsin.
** All currently employed non-active duty military respondents to the Industry and Occupation module of the 2017 or 2018 Behavioral Risk Factor Surveillance System.
†† Except nonmelanoma skin cancer.
§§ Includes heart attack/myocardial infarction, coronary heart disease, or angina.
¶¶ Relative standard error >30% but ≤50%.
*** 2017 BRFSS data only, available for 22 states: California, Connecticut, Florida, Georgia, Hawaii, Illinois, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Tennessee, Washington, and Wisconsin.
††† Body mass index (and thus obesity) was missing for 9% of cohort; all other behaviors and conditions missing for <1% of cohort.